Abstract purpose: To determine the long-term impact of medical and surgical treatment of
well differentiated papillary and follicular thyroid cancer. methods: Patients with papillary …

Long-term survival rate for papillary and follicular carcinoma is more than 90%, but this
varies considerably among subsets of patients. About 30% of patients, however, develop …

This report from the Canadian survey of thyroid cancer describes 1,074 patients with
papillary thyroid cancer and 504 with follicular thyroid cancer followed for four to 24 years …

Outcome was compared in 1004 patients with differentiated thyroid carcinoma (DTC) who
underwent thyroid remnant ablation with 131I (n= 151) or were either treated with thyroid …

Background: Treatment of differentiated thyroid cancer has been studied for many years, but
the benefits of extensive initial thyroid surgery and the addition of radioiodine therapy or …

Objective To determine, based on published literature and expert clinical experience,
current indications for the post-surgical administration of a large radioiodine activity in …

Background. There have been numerous studies concerning the diagnosis, treatment, and
prognosis of patients with papillary thyroid carcinoma, but relatively few addressing patients …

Papillary and follicular thyroid cancer, together referred to as differentiated thyroid cancer
(DTC), is usually curable when discovered at an early stage. Its management, however, is …

GENERAL aspects of the diagnosis and management of differentiated thyroid carcinoma
(DTC) have been reviewed recently (1) and guidelines for management proposed (2). Yet …

We retrospectively analyzed the outcome of all patients who received their primary treatment
for follicular thyroid cancer at the Mayo Clinic between 1946 and 1970. The diagnosis was …